Therefore, elucidating the oncogenic role of ALPP in CCA is of great scientific interest, as it may not only enhance our understanding of its functional contribution to tumor progression but also facilitate the identification of novel prognostic biomarkers and therapeutic targets, ultimately advancing the diagnosis and treatment strategies for cholangiocarcinoma. This evidence concerns the gene ALPP and cholangiocarcinoma.